1244 ET - WELL Health Technologies is continuing its Canada-focused play, buying up more clinics as it sheds its U.S. operations. The company closed two sizeable clinic acquisitions--Ontario Imaging Diagnostics, a diagnostic imaging and procedure care provider, and a 65% controlling interest in Quebec-based UnionMD--and now expects to exceed its previous adjusted Ebitda guidance of C$175-C$185 million. TD Cowen analyst David Kwan says move reaffirms "a significant re-rating as it sells its U.S. businesses and redeploys the capital into the very attractive Canadian market." He adds that the increased outlook, which is 4% above consensus, should help assuage concerns about company margins and expect the year-to-date share price outperformance to continue. Shares are up 3.7% to C$4.76. (adriano.marchese@wsj.com)

(END) Dow Jones Newswires

June 02, 2026 12:45 ET (16:45 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.